clinical trial · NCT00648531
Fasting Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mg
HealthyBalsalazide Disodium Capsules 750 mgColazal® Capsules 750 mg
brief summary
The objective of this study was to investigate the bioequivalence of Mylan balsalazide disodium 750 mg capsules and Salix Colazal® 750 mg capsules following a single, oral 2250 mg (3 x 750 mg) dose administration under fasting conditions.
started
May 1, 2004
primary completion
May 1, 2004
completion
May 1, 2004
last updated
Apr 24, 2024
official title
Single-Dose Fasting In Vivo Bioequivalence Study of Balsalazide Disodium Capsules (750 mg; Mylan) and Colazal® Capsules (750 mg; Salix) in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol